Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
CJEM ; 23(5): 715-716, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34146299
4.
J Gastrointest Surg ; 23(8): 1682-1693, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-31062270

RESUMO

BACKGROUND: Perioperative carbohydrate loading, increased protein intake, and immunonutrition may decrease postoperative complications. Studies on the topic have led to controversial results. METHODS: We searched Medline, EMBASE, and CENTRAL up to August 2018 for randomized trials comparing the effect of perioperative nutritional supplements (intervention) versus control on postoperative complications in patients undergoing gastrointestinal cancer surgery. Secondary outcomes included infectious complications and length of hospital stay (LOS). Random effects model was used to estimate the pooled risk ratio (RR) of treatment effects. Pooled mean difference (MD) was used to compare LOS. Heterogeneity was assessed using I2. Sources of heterogeneity were explored through subgroup analysis by nutritional supplementation protocol, type of surgery, and type of nutritional supplement. Risk of bias and quality of the evidence were assessed. RESULTS: Of 3951 articles, we identified 56 trials (n = 6370). Perioperative nutrition was associated with a lower risk of postoperative complications (RR 0.74, 95% confidence interval (CI) 0.69-0.80); postoperative infections (RR 0.71, 95% CI 0.64-0.79, n = 4582); and postoperative non-infectious complications (RR 0.79, 95% CI 0.71-0.87, n = 4883). There were no significant heterogeneity outcomes analyzed (I2 = 14%, 1%, and 7%, respectively). LOS was shorter for the intervention group, MD - 1.58 days; 95% CI - 1.83 to - 1.32; I2 = 89%). Subgroup analysis did not identify sources of heterogeneity. The quality of evidence for postoperative complications was high and for LOS was moderate. CONCLUSION: Perioperative nutritional optimization decreases the risk of postoperative infectious and non-infectious complications. It also decreases LOS in patients undergoing gastrointestinal cancer surgery, but these findings should be taken with caution given the high heterogeneity.


Assuntos
Suplementos Nutricionais , Procedimentos Cirúrgicos do Sistema Digestório , Estado Nutricional , Assistência Perioperatória/métodos , Complicações Pós-Operatórias/prevenção & controle , Humanos , Tempo de Internação/tendências
5.
Plast Surg (Oakv) ; 27(1): 54-65, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30854363

RESUMO

BACKGROUND: The National Surgical Quality Improvement Program (NSQIP) is a robust, high-quality surgical outcomes database that measures risk-adjusted 30-day outcomes of surgical interventions. The purpose of this scoping review is to describe how the NSQIP is being used in plastic surgery research. METHODS: A comprehensive electronic literature search was completed in PubMed, Embase, MEDLINE, and CINAHL. Two reviewers independently reviewed articles to determine their relevance using predefined inclusion criteria. Articles were included if they utilized NSQIP data to conduct research in a domain of plastic surgery or analyzed surgical procedures completed by plastic surgeons. Extracted information included the domain of plastic surgery, country of origin, journal, and year of publication. RESULTS: A total of 106 articles met the inclusion criteria. The most common domain of plastic surgery was breast reconstruction representing 35% of the articles. Of the 106 articles, 95% were published within the last 5 years. The Plastic and Reconstructive Surgery journal published most of the (59%) NSQIP-related articles. All of the studies were retrospective. Of note, there were no articles on burns and only one study on trauma as the domain of plastic surgery. CONCLUSION: This scoping review describes how NSQIP data are being used to analyze plastic surgery interventions and outcomes in order to guide quality improvement in 106 articles. It demonstrates the utility of NSQIP in the literature, however also identifies some limitations of the program as it applies to plastic surgery.


HISTORIQUE: Le Programme national d'amélioration de la qualité des soins chirurgicaux (PNAQC) est une base de données des résultats chirurgicaux à la fois solide et de qualité, qui mesure les résultats des interventions chirurgicales rajustées au risque au bout de 30 jours. La présente étude exploratoire vise à décrire le mode d'utilisation du PNAQC dans la recherche en chirurgie plastique. MÉTHODOLOGIE: Les chercheurs ont procédé à une analyse bibliographique électronique fouillée dans PubMed, Embase, MEDLINE et CINAHL. À l'aide de critères d'inclusion prédéfinis, deux analystes ont examiné des articles de manière indépendante pour en déterminer la pertinence. Ils ont inclus les articles qui utilisaient les données du PNAQC pour mener des recherches dans un domaine de la chirurgie plastique ou analyser les interventions chirurgicales effectuées par des plasticiens. L'information extraite incluait le domaine de la chirurgie plastique, le pays d'origine, la revue scientifique et l'année de publication. RÉSULTATS: Au total, 106 articles respectaient les critères d'inclusion. Le principal domaine de chirurgie plastique était la reconstruction mammaire, qui représentait 35 % des articles. Des 106 articles, 95 % avaient été publiés au cours des cinq années précédentes. La revue Plastic and Reconstructive Surgery avait publié la plupart des articles liés au PNAQC (59 %). Toutes les études étaient rétrospectives. Il est à souligner que, pour ce qui est du domaine de la chirurgie plastique, une seule étude portait sur les brûlures et aucune, sur les traumatismes. CONCLUSION: La présente étude exploratoire décrit le mode d'utilisation des données du PNAQC pour analyser les interventions en chirurgie plastique et leurs résultats pour orienter les améliorations de la qualité dans de 106 articles. Elle démontre l'utilité du PNAQC dans les publications, mais fait également ressortir certaines limites de ce dansgramme en chirurgie plastique.

7.
J Craniofac Surg ; 29(4): 1006-1011, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29561480

RESUMO

Posttraumatic enophthalmos due to isolated or complex orbital fractures can contribute to diplopia. Current evidence recommends early repair. However, little is known about the outcome of enophthalmos correction when repair occurs beyond 30 days after trauma. In this systematic review, the authors aim to evaluate the current evidence on functional outcomes after delayed repair of posttraumatic enophthalmos.Two independent assessors undertook a systematic review of the literature using multiple databases. The authors' inclusion criteria identified studies involving patients at least 14 years of age who had surgical correction of persistent enophthalmos 30 days after initial trauma. Each eligible paper was included after critical appraisal using validated guidelines. Data on preoperative and postoperative enophthalmos and diplopia in each study was extracted. The pattern of fracture was also noted.The authors' search for the medical databases yielded 1053 articles, of which 6 eligible papers were included. Meta-analysis was performed. In patients with complex injuries involving orbital and mid-facial fractures, diplopia resolution was calculated to be 53%, and enophthalmos was corrected in 83% of the patients. In patients with isolated orbital fractures, 53% had resolution of their diplopia, and enophthalmos was corrected in 88% of the patients.Enophthalmos can be corrected to within 2 mm of the contralateral eye in both the isolated and complex orbital fractures in patients who present 30 days or greater after injury. Based on the studies reviewed, there is less predictability in diplopia resolution.


Assuntos
Diplopia , Enoftalmia , Traumatismos Faciais/cirurgia , Diplopia/epidemiologia , Diplopia/etiologia , Enoftalmia/complicações , Enoftalmia/epidemiologia , Enoftalmia/cirurgia , Traumatismos Faciais/complicações , Traumatismos Faciais/epidemiologia , Humanos , Resultado do Tratamento
8.
Neurobiol Dis ; 106: 133-146, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28673739

RESUMO

Parkinson's disease (PD) is a neurodegenerative movement disorder, which affects approximately 1-2% of the population over 60years of age. Current treatments for PD are symptomatic, and the pathology of the disease continues to progresses over time until palliative care is required. Mitochondria are key players in the pathology of PD. Genetic and post mortem studies have shown a large number of mitochondrial abnormalities in the substantia nigra pars compacta (SNc) of the parkinsonian brain. Furthermore, physiologically, mitochondria of nigral neurons are constantly under unusually high levels of metabolic stress because of the excitatory properties and architecture of these neurons. The protein deacetylase, Sirtuin 3 (SIRT3) reduces the impact subcellular stresses on mitochondria, by stabilising the electron transport chain (ETC), and reducing oxidative stress. We hypothesised that viral overexpression of myc-tagged SIRT3 (SIRT3-myc) would slow the progression of PD pathology, by enhancing the functional capacity of mitochondria. For this study, SIRT3-myc was administered both before and after viral induction of parkinsonism with the AAV-expressing mutant (A53T) α-synuclein. SIRT3-myc corrected behavioural abnormalities, as well as changes in striatal dopamine turnover. SIRT3-myc also prevented degeneration of dopaminergic neurons in the SNc. These effects were apparent, even when SIRT3-myc was transduced after the induction of parkinsonism, at a time point when cell stress and behavioural abnormalities are already observed. Furthermore, in an isolated mitochondria nigral homogenate prepared from parkinsonian SIRT3-myc infected animals, SIRT3 targeted the mitochondria, to reduce protein acetylation levels. Our results demonstrate that transduction of SIRT3 has the potential to be an effective disease-modifying strategy for patients with PD. This study also provides potential mechanisms for the protective effects of SIRT3-myc.


Assuntos
Mitocôndrias/metabolismo , Neurônios/metabolismo , Neuroproteção/fisiologia , Transtornos Parkinsonianos/metabolismo , Sirtuína 3/metabolismo , alfa-Sinucleína/metabolismo , Acetilação , Animais , Linhagem Celular Tumoral , Dependovirus/genética , Feminino , Vetores Genéticos , Humanos , Masculino , Camundongos Endogâmicos C57BL , Mitocôndrias/patologia , Mutação , Neurônios/patologia , Biogênese de Organelas , Transtornos Parkinsonianos/patologia , Ratos Sprague-Dawley , Sirtuína 3/genética , Substância Negra/metabolismo , Substância Negra/patologia , alfa-Sinucleína/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA